RT @theA4LI: 🚨 LAST CHANCE TO SIGN! 🚨 The Senate Special Committee on Aging is meeting next week, and this is your final opportunity to ad…

Today, our postbaccs & grad intern joined "Career Speed Dating," connecting with professionals who took non-academic paths after their PhDs. Thanks to our guests for sharing their expertise & helping students explore diverse careers! @SciCo_ @Elanco @Neurocrine @WNuhsbaum

Dr. O’Connor of @Cyclarity spoke to about UDP-003, a drug targeting atherosclerosis. Cyclarity is entering trials & success could save millions. Good luck to Cyclarity, CMAX, @MonashUni, & Dr. Nicholls! Interview: By: Steve Hill

RT @LifespanIO: Scientists from @LifespanRI and the @BuckInstitute have published findings that Urolithin A may help reduce senescence and…

Thank you to everyone who joined us at @SHACK15sf to help kick off the @jpmorgan Healthcare Conference in San Francisco! It was an afternoon of inspiring discussions and meaningful connections in the longevity biotech space.

As we begin this new year for the first time as a newly merged organization, we want to extend a huge thank you to everyone who supported our End of Year campaign. Because of you, we’re starting 2025 with even more energy and determination. Here's to a year of progress!

📢 Last chance to make an impact in 2024! Donate before midnight and help drive progress toward longer, healthier lives. Your contribution funds vital research and innovation to address the challenges of aging. ➡️

As we approach the end of the year, there’s still time to make a difference in the fight for longer, healthier lives. At LRI, we’re dedicated to advancing research that targets the root causes of aging, but we can’t do it without you. Act now.

Top Stories of 2024: Editor's Pick #2 Arkadi Mazin of delves deeper into the 2024 paper titled “Implausibility of radical life extension in humans in the twenty-first century”.

Help us continue to drive this and other groundbreaking longevity research by donating to our End of Year Campaign today! Support Now: ➡️

At LRI, a core part of our mission is to train and mentor young scientists, fueling the future of longevity research. Please help us continue to empower students and advance the field of longevity biotech by making your gift today. Donate Now:

As #GivingWeek comes to a close, we want to say thank you for the incredible support. With just a few weeks left in the year, we’re asking for your help to finish 2024 strong. Every dollar donated brings us closer to longer, healthier lives.

Major milestone achieved by LRI's Dr. Boominathan and her team who - for the first time - allotopically expressed a mitochondrial gene in vivo and showed successful incorporation into the electron transport chain in mammals (mice). By: @ArkadyMazin

Thanks to Longevity Global for bringing together leaders from across the field at the Longevity Summit 2024 this week at the Buck Institute for Aging! LRI was proudly represented by Dr. Amit Sharma, @ArkadyMazin, and Dr. Emily Lillian Fishman. @LongevityGL @BuckInstitute

Join us this #GivingTuesday in our fight against age-related diseases like Alzheimer’s, cancer, atherosclerosis, and sarcopenia. Make this @GivingTuesday count by making your donation to Lifespan Research Institute and #longevity research today.

We are excited to congratulate Jim O’Neil on his nomination as HHS Deputy Secretary. Former CEO of SENS Research Foundation (now merged with to form LRI) Jim has extensive experience within longevity biotech. @regardthefrost

Fact: The risk of disease increases exponentially with age. We're developing therapies targeting the root causes of aging to reduce the risk of multiple age-related diseases simultaneously, greatly improving health. Donate today: Graph Credit: @LBF_org